Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olin

Showing results (1271-1280 of 1,715) with videos related to

Pageof 172
Sort By:
Molecular Microbiology|December 21, 2007
The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenesMaria Nilsson, Sylwia Wasylik, Matthias Mörgelin, et al.
Contemporary Clinical Trials|June 23, 2020
A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: A novel design for a novel treatmentCharles R Conway, Bryan Olin, Scott T Aaronson, et al.
Human Gene Therapy|June 24, 2004
Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial diseaseSanjay Rajagopalan, Jeffrey W Olin, Stuart Young, et al.
Vascular Medicine (London, England)|January 10, 2022
Cardiovascular manifestations of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disordersEman R Rashed, Tania Ruiz Maya, Jennifer Black, et al.
Journal of Innate Immunity|April 9, 2010
Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin systemSara H Bengtson, Caroline Sandén, Matthias Mörgelin, et al.
Regulatory Toxicology and Pharmacology : RTP|March 29, 2003
The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzeneRichard Albertini, Harvey Clewell, Matthew W Himmelstein, et al.
Circulation|September 28, 2011
Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudicationMark A Creager, Jeffrey W Olin, Jill J F Belch, et al.
BMC Research Notes|November 9, 2015
Development and characterization of 33 novel polymorphic microsatellite markers for the brown tree snake Boiga irregularisShem D Unger, Erin F Abernethy, Stacey L Lance, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 7, 2016
On the regulatory importance of 27-hydroxycholesterol in mouse liverMaura Heverin, Zeina Ali, Maria Olin, et al.
Therapeutic Advances in Gastroenterology|October 23, 2018
Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel diseaseViktoria Bergqvist, Mohammad Kadivar, Daniel Molin, et al.
Pageof 172

Showing results (1271-1280 of 1,715) with videos related to

Sort By:
Pageof 172
Molecular Microbiology|December 21, 2007
The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenesMaria Nilsson, Sylwia Wasylik, Matthias Mörgelin, et al.
Contemporary Clinical Trials|June 23, 2020
A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: A novel design for a novel treatmentCharles R Conway, Bryan Olin, Scott T Aaronson, et al.
Human Gene Therapy|June 24, 2004
Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial diseaseSanjay Rajagopalan, Jeffrey W Olin, Stuart Young, et al.
Vascular Medicine (London, England)|January 10, 2022
Cardiovascular manifestations of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disordersEman R Rashed, Tania Ruiz Maya, Jennifer Black, et al.
Journal of Innate Immunity|April 9, 2010
Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin systemSara H Bengtson, Caroline Sandén, Matthias Mörgelin, et al.
Regulatory Toxicology and Pharmacology : RTP|March 29, 2003
The use of non-tumor data in cancer risk assessment: reflections on butadiene, vinyl chloride, and benzeneRichard Albertini, Harvey Clewell, Matthew W Himmelstein, et al.
Circulation|September 28, 2011
Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudicationMark A Creager, Jeffrey W Olin, Jill J F Belch, et al.
BMC Research Notes|November 9, 2015
Development and characterization of 33 novel polymorphic microsatellite markers for the brown tree snake Boiga irregularisShem D Unger, Erin F Abernethy, Stacey L Lance, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 7, 2016
On the regulatory importance of 27-hydroxycholesterol in mouse liverMaura Heverin, Zeina Ali, Maria Olin, et al.
Therapeutic Advances in Gastroenterology|October 23, 2018
Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel diseaseViktoria Bergqvist, Mohammad Kadivar, Daniel Molin, et al.
Pageof 172